APOLD1 and stroke disorder: Labeling of proliferating cells one week after stroke using 5-ethynyl-2’-deoxyuridine (EdU) injections combined with immunofluorescent labeling of PECAM1+ ECs showed that Apold1−/− ECs within the ischemic border zone proliferate less (Fig. 3G, I).